Abstract
This paper discusses the challenges facing health technology assessment (HTA) in Europe, based on an explicit analysis of the characteristics of an "optimal" HTA system. It has three objectives: a) to elaborate an explicit system of policy goals and the characteristics of an optimal HTA system that facilitates the achievement of these goals; b) to identify the general institutional incentive barriers (government and market failures) that prevent the attainment of an optimal HTA system in Europe; and c) to argue that evaluation of the implications of health technologies for equity and inequality in health is an essential part of this optimal system and a considerable challenge for HTA decision makers. especially as national governments realign policy toward equity goals.
| Original language | English |
|---|---|
| Pages (from-to) | 639-650 |
| Number of pages | 12 |
| Journal | International Journal of Technology Assessment in Health Care |
| Volume | 16 |
| Issue number | 2 |
| Publication status | Published - 2000 |
Keywords
- technology assessment
- biomedical
- evidence-based medicine
- evaluation research
- healthcare quality
- access and evaluation
- EVIDENCE-BASED MEDICINE
- ECONOMIC-EVALUATION
- CARE
- SERVICE
- EQUITY
- UK